20-F: Cordyceps Sunshine Biotech Holdings Co. Ltd. Files 20-F Annual Report, Details Patent Licensing and Financial Performance

Cordyceps Sunshine Biotech Holdings Co., Ltd. files its 20-F annual report, outlining a patent exclusive license agreement, financial results, and risk factors.

Summary

• Cordyceps Sunshine Biotech Holdings Co., Ltd. has filed its 20-F annual report.
• The report details a patent exclusive license agreement for cattle camphor mushroom cultivation technologies.
• The company generated revenue of $882,533 in 2023, primarily from cattle camphor mushroom products.
• A net income of $823,860 was reported for 2023, a significant turnaround from a net loss of $720,093 in 2022.
• The company spun off its Cordyceps business in September 2023.
• The report outlines various risk factors, including reliance on a few products and suppliers, and risks associated with doing business in Taiwan.
• The company plans to harvest its own cattle camphor mushroom raw materials in 2025.
• The company has negative working capital of $2,597,947 as of December 31, 2023.
• The company plans to obtain capital from management to meet minimal operating expenses and seek third party equity and/or debt financing.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While the company achieved profitability in 2023 and secured key licensing agreements, it also faces significant financial challenges, including negative working capital and reliance on external funding. The risk factors and going concern matter raise concerns about the company's long-term viability.

Positives

• The company secured exclusive rights to use six cultivation technologies for cattle camphor mushroom.
• The company achieved a significant turnaround in financial performance, reporting a net income of $823,860 in 2023.
• The company is actively cultivating its own raw materials, which is expected to reduce reliance on external suppliers.
• Gross margin for third party sales was $674,482, or 88.66% for the year ended December 31, 2023.

Negatives

• The company has a going concern matter due to not yet establishing an ongoing source of revenues and cash flows sufficient to cover the operating costs and allow it to continue as a going concern.
• The company has negative working capital of $2,597,947 as of December 31, 2023.
• The company relies on a single supplier for raw materials.
• The company had one major customer, who accounted for 14.49% of the revenue for the fiscal year ended December 31, 2023.
• The company's disclosure controls and procedures were ineffective as of December 31, 2023 due to a material weakness identified in our internal control over financial reporting.

Risks

• The company's business is subject to export regulations in Taiwan.
• Instability in international markets or foreign currency fluctuations could adversely affect the company's results of operations.
• The company depends on single-source suppliers for some of the products it sells.
• The company may require substantial additional funding in the future for its ability to continue as a going concern.
• The company's sales and reputation may be affected by product liability claims, product recalls, pests contamination risks, or adverse publicity in relation to its products.
• The market price for the ordinary shares may be volatile.
• The highly concentrated ownership and voting power of the Company may impact shareholders interests in the Company.

Future Outlook

The company expects to harvest its own cattle camphor mushroom raw materials in 2025 and plans to expand its product offerings and online presence.

Industry Context

The report notes the growing demand for Cordyceps and cattle camphor mushroom in both domestic and international markets, highlighting the potential for growth in the industry.

Comparison to Industry Standards

• The significance of the Cattle camphor mushroom industry in Taiwan parallels that of Korean ginseng and Chinese Cordyceps.
• The demand for Cattle camphor mushroom has experienced remarkable growth, driven by various factors.
• According to industry reports by Chinese Association of Traditional Chinese Medicine, Analysis of the Cattle camphor mushroom Industry in 2023, the market demand within China is 2812.13 tons in 2023 and is expected to reach 4341.34 tons by 2027, with an annual growth rate of range from 9-12%.

Corporate Governance

Legal Proceedings

• We may from time to time become a party to various legal or administrative proceedings arising in the ordinary course of our business.
• As of the date hereof, neither we nor any of our subsidiaries is a party to any pending legal proceedings, nor are we aware of any such proceedings threatened against us or our subsidiaries.

Related Party Transactions

• The Company sold newly developed products processed with cordyceps and taiwanofungus of $121,811, $ $53,304 and $0 to Gasar Biotechnology Co., Ltd. For the years ended December 31, 2023, 2022 and 2021 respectively.
• The related cost of revenue was $29,906, $13,746 and $0 for the years ended December 31, 2023, 2022 and 2021 respectively.

Stakeholder Impact

• Shareholders are subject to risks associated with the company's financial condition and reliance on external funding.
• Employees face potential job security concerns due to the company's going concern matter.
• Customers may be affected by potential product liability claims or recalls.
• Suppliers are subject to risks associated with the company's ability to meet its financial obligations.
• Creditors face risks associated with the company's negative working capital and reliance on external funding.

Next Steps

• The company plans to harvest its own cattle camphor mushroom raw materials in 2025.
• The company plans to expand its product offerings with diversified Cattle camphor mushroom specialty items and establish an online presence in Hong Kong, China, Japan, and the United States through e-commerce platforms.
• The company aims to deepen collaboration with raw material agents, health food manufacturers, and biotech pharmaceutical companies to further penetrate the market and broaden our reach.

Key Dates

Keywords

cattle camphor mushroom, Cordyceps, Taiwanofungus, patent, license, cultivation, financial results, risk factors, biotech